Sundar.M
☆    

India,
2019-02-15 12:37
(751 d 11:28 ago)

Posting: # 19925
Views: 1,057
 

 Dose curve [PK / PD]

Dear all,

How to choose dose for any PK/PD study (without non-clinical data) in healthy volunteer for Phase-1 trials for already marketed product? Other words, how to choose the proposed dose to detect clinically meaningful differences in PK/PD responses?

Thanks for your help.

Thanks
MSMN
Activity
 Admin contact
21,371 posts in 4,463 threads, 1,496 registered users;
online 7 (0 registered, 7 guests [including 3 identified bots]).
Forum time: Monday 00:06 UTC (Europe/Vienna)

When puzzled, it never hurts to read the primary documents 
a rather simple and self-evident principle that has, nonetheless,
completely disappeared from large sectors
of the American experience.    Stephen Jay Gould

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5